303 related articles for article (PubMed ID: 8973548)
81. Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788.
Demmer A; Dunn T; Hoof T; Kubesch P; Tümmler B
Eur J Pharmacol; 1996 Nov; 315(3):339-43. PubMed ID: 8982674
[TBL] [Abstract][Full Text] [Related]
82. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
[TBL] [Abstract][Full Text] [Related]
83. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
[TBL] [Abstract][Full Text] [Related]
84. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Biochemistry; 2006 Jul; 45(29):8940-51. PubMed ID: 16846237
[TBL] [Abstract][Full Text] [Related]
85. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.
Cisternino S; Rousselle C; Debray M; Scherrmann JM
Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515
[TBL] [Abstract][Full Text] [Related]
86. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
Sharom FJ; Yu X; Chu JW; Doige CA
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):381-90. PubMed ID: 7772017
[TBL] [Abstract][Full Text] [Related]
87. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
Bruggemann EP; Germann UA; Gottesman MM; Pastan I
J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
[TBL] [Abstract][Full Text] [Related]
88. Reconstitution of purified P-glycoprotein into liposomes.
Naito M; Tsuruo T
J Cancer Res Clin Oncol; 1995; 121(9-10):582-6. PubMed ID: 7559741
[TBL] [Abstract][Full Text] [Related]
89. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
90. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
91. Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.
Greenberger LM; Lisanti CJ; Silva JT; Horwitz SB
J Biol Chem; 1991 Nov; 266(31):20744-51. PubMed ID: 1682313
[TBL] [Abstract][Full Text] [Related]
92. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1998 May; 254(1):189-93. PubMed ID: 9652413
[TBL] [Abstract][Full Text] [Related]
93. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
Tomida A; Tatsuta T; Suzuki H
Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
[TBL] [Abstract][Full Text] [Related]
94. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
Safa AR
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):1-17. PubMed ID: 14754408
[TBL] [Abstract][Full Text] [Related]
95. Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.
Bates SE; Currier SJ; Alvarez M; Fojo AT
Biochemistry; 1992 Jul; 31(28):6366-72. PubMed ID: 1352990
[TBL] [Abstract][Full Text] [Related]
96. P-glycoprotein inhibition by glibenclamide and related compounds.
Golstein PE; Boom A; van Geffel J; Jacobs P; Masereel B; Beauwens R
Pflugers Arch; 1999 Apr; 437(5):652-60. PubMed ID: 10087141
[TBL] [Abstract][Full Text] [Related]
97. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.
Litman T; Zeuthen T; Skovsgaard T; Stein WD
Biochim Biophys Acta; 1997 Aug; 1361(2):159-68. PubMed ID: 9300797
[TBL] [Abstract][Full Text] [Related]
98. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
[TBL] [Abstract][Full Text] [Related]
99. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
100. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1.
Zhang X; Collins KI; Greenberger LM
J Biol Chem; 1995 Mar; 270(10):5441-8. PubMed ID: 7890659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
